ask="44.50"
ask_size="100"
average_daily_volume="1126750"
bid="39.29"
bid_size="1000"
book_value="4.05"
change="+2.78"
change_from_200_day_moving_average="-3.77"
change_from_50_day_moving_average="2.00"
change_from_52_week_high="-12.24"
change_From_52_week_low="11.66"
change_in_percent="+6.93%"
close="42.91"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-1.45"
ebitda="-134.59M"
eps_estimate_current_year="-1.63"
eps_estimate_next_quarter="-0.48"
eps_estimate_next_year="-1.92"
ex_dividend_date="N/A"
float_shares="85794000"
high="43.00"
high_52_weeks="55.15"
last_trade_date="1/31/2017"
last_trade_price="42.91"
last_trade_size="59197"
last_trade_time="4:00pm"
low="39.28"
low_52_weeks="31.25"
market_capitalization="3.73B"
moving_average_200_day="46.68"
moving_average_50_day="40.91"
name="Neurocrine Biosciences
Inc."
notes="N/A"
one_year_target_price="66.92"
open="39.63"
pe_ratio="N/A"
peg_ratio="0.68"
percent_change_from_200_day_moving_average="-8.08%"
percent_change_from_50_day_moving_average="+4.88%"
percent_change_from_52_week_high="-22.19%"
percent_change_from_52_week_low="+37.31%"
previous_close="40.13"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="9.91"
price_per_sales="232.41"
revenue="15.00M"
shares_outstanding="86871000"
short_ratio="3.10"
stock_exchange="NMS"
symbol="NBIX"
volume="1399566"
weeks_range_52="31.25 - 55.15"
